Rahsaan Thompson, Chief Legal & Compliance at ZEVRA THERAPEUTICS, INC. (ZVRA), sold 34,557 shares at $12.68 ($438K) on 2026-06-22, disclosed to the SEC on 2026-06-23.
Scheduled sale ($438k) by Chief Legal & Compliance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ZVRA | SELL | 2026-02-02 | $72K | — | Filing → |
| ZVRA | SELL | 2025-06-30 | $442K | — | Filing → |